U.S. Markets closed

Acceleron Pharma Inc. (XLRN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
126.49-5.98 (-4.51%)
At close: 4:00PM EST

126.49 0.00 (0.00%)
After hours: 4:30PM EST

Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 0.61
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 3136.25
52 Week Low 350.80
50-Day Moving Average 3125.06
200-Day Moving Average 3109.70

Share Statistics

Avg Vol (3 month) 3309.82k
Avg Vol (10 day) 3409.4k
Shares Outstanding 560.25M
Float 52.96M
% Held by Insiders 112.18%
% Held by Institutions 190.06%
Shares Short (Dec 30, 2020) 42.73M
Short Ratio (Dec 30, 2020) 48.88
Short % of Float (Dec 30, 2020) 46.03%
Short % of Shares Outstanding (Dec 30, 2020) 44.53%
Shares Short (prior month Nov 29, 2020) 43.18M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Sep 29, 2020

Profitability

Profit Margin -124.73%
Operating Margin (ttm)-127.64%

Management Effectiveness

Return on Assets (ttm)-11.52%
Return on Equity (ttm)-19.44%

Income Statement

Revenue (ttm)105.99M
Revenue Per Share (ttm)1.93
Quarterly Revenue Growth (yoy)436.10%
Gross Profit (ttm)-79.96M
EBITDA -131.44M
Net Income Avi to Common (ttm)-132.21M
Diluted EPS (ttm)-2.40
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)882.36M
Total Cash Per Share (mrq)14.65
Total Debt (mrq)21.85M
Total Debt/Equity (mrq)2.44
Current Ratio (mrq)24.50
Book Value Per Share (mrq)14.91

Cash Flow Statement

Operating Cash Flow (ttm)-108.45M
Levered Free Cash Flow (ttm)-66.5M